News Tag: English

First patient in the European Heart Preservation study transplanted

  • 14:00

The first patient in XVIVOs European Heart preservation study was transplanted during the month of November. The patent protected Heart Preservation device, developed by Professor Stig Steen and commercialized by XVIVO, uses a novel technique for preservation of the donor heart during transport. Nine European transplant centers will include a total of 202 patients in the trial that forms the basis of a European regulatory approval application and will investigate if the new technology can improve patient outcome and reduce complications after heart transplantation.

Read more

Publication in The Lancet shows better survival of transplanted kidneys after cold machine perfusion with oxygen

  • 07:30

An article published in the scientific journal The Lancet today, shows that oxygenated perfusion of kidneys before transplantation has a significant impact on the first-year result after transplantation: less graft failure, better function and lower rejection of the kidney when compared to cold perfusion alone. The randomized trial, with kidneys aged 50 years or older, donated after circulatory death was done in 19 European transplant centers and included 212 patients. The Kidney Assist Transport device, used in the trial described in the Lancet article, is CE-marked and XVIVO intends to submit an application to the FDA during 2021 for the device.

Read more

Conference call on Interim Report

  • 14:00

Invitation to attend XVIVO Perfusion’s conference call regarding the presentation of the interim report July – September 2020. The presentation will be held in English.

Read more